Company news
Seaport Therapeutics, Inc. (NASDAQ:SPTX) news
Seaport Therapeutics, Inc. news releases on 6ix. Latest, Sep 14, 2026: Seaport Therapeutics to Participate in September Investor Conferences
Press releases & updates
Seaport Therapeutics to Participate in September Investor Conferences
September 14, 2026
Seaport Therapeutics Reports Positive Topline Results from Phase 1 Driving Simulation Trial of GlyphAllo™ in Healthy Volunteers
September 9, 2026
Seaport Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
August 3, 2026
PureTech Founded Entity Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™ in Healthy Volunteers
June 8, 2026
Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™ in Healthy Volunteers
June 7, 2026
Seaport Therapeutics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
June 7, 2026
Seaport Therapeutics to Participate in Two Upcoming Investor Conferences
May 31, 2026
Seaport Therapeutics Announces Pricing of Upsized Initial Public Offering
April 30, 2026